Lipoxin A4 analogs

Details for Australian Patent Application No. 2002348167 (hide)

Owner Schering Aktiengesellschaft

Inventors Subramanyam, Babu; Bauman, John G; Parkinson, John F; Skuballa, Werner; Guilford, William J

Agent Davies Collison Cave

Pub. Number AU-B-2002348167

PCT Number PCT/US02/35318

PCT Pub. Number WO2003/040080

Priority 10/279,084 22.10.02 US; 60/338,684 06.11.01 US

Filing date 5 November 2002

Wipo publication date 19 May 2003

Acceptance publication date 21 May 2009

International Classifications

C07D 317/40 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/19 (2006.01)

A61K 31/202 (2006.01)

A61K 31/216 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/39 (2006.01) - having oxygen atoms in the same ring

A61K 31/42 (2006.01) - Oxazoles

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 Drugs for disorders of the senses

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 10/279,084 22.10.02 US; 60/338,684 06.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002348167

29 March 2007 Amendment Made

  The nature of the amendment is: Add priority details 10/279,084 22 Oct 2002 US 2003

21 May 2009 Application Accepted

  Published as AU-B-2002348167

28 May 2009 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft 2003

17 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002348168-METHODS AND SYSTEMS FOR ASSOCIATING AN IDENTITY OF A SENDER WITH A PARCEL SENT VIA A COURIER

2002348166-METHOD AND APPARATUS FOR THE TREATMENT OF PARTICULATE BIODEGRADABLE ORGANIC WASTE